Oxford Centre for Diabetes, Endocrinology and Metabolism
OCDEM is a pioneering centre that combines clinical care, research and education in diabetes, endocrine and metabolic diseases. By promoting world-class research, we aim to enhance understanding of these diseases and to accelerate the search for new treatments and cures.
A critical role of the mechanosensor PIEZO1 in glucose-induced insulin secretion in pancreatic β-cells.
Ye Y. et al, (2022), Nat Commun, 13
TCF7L2 plays a complex role in human adipose progenitor biology, which might contribute to genetic susceptibility to type 2 diabetes.
Verma M. et al, (2022), Metabolism, 133
Age-dependent changes in protein incorporation into collagen-rich tissues of mice by in vivo pulsed SILAC labelling
Ariosa-Morejon Y. et al, (2021), eLife, 10
Li M. et al, (2021), Nature Communications, 12
Verkouter I. et al, (2021), The Journal of Clinical Endocrinology & Metabolism
Genetic variant effects on gene expression in human pancreatic islets and their implications for T2D.
Viñuela A. et al, (2020), Nat Commun, 11
Haythorne E. et al, (2019), Nat Commun, 10
3 November 2022
This year's winners are Edward Jenkins, Antje Rottner, and Akshay Shah.
27 September 2022
Dr Shilpa Nagarajan is one of the MPLS Enterprise and Innovation Fellows for 2022-23.
Intensive blood glucose control for people with type 2 diabetes when they are first diagnosed reduces diabetic complications and prolongs life
21 September 2022
The study, which tracked volunteers for up to 44 years, showed that the benefits of early intensive blood glucose control can persist for decades.
View previous and upcoming events in OCDEM.